Skip to content
healthcare.dev

OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE

NDC 50228-344, OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, tablet, film coated, from ScieGen Pharmaceuticals Inc.

Product NDC
50228-344
Status
Listed
Labeler
ScieGen Pharmaceuticals Inc
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208465
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-344 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLMESARTAN MEDOXOMIL40 mg/1
  • HYDROCHLOROTHIAZIDE25 mg/1

Pharmacologic classes

Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
50228-344-10502280344101000 TABLET, FILM COATED in 1 BOTTLE (50228-344-10)
50228-344-305022803443030 TABLET, FILM COATED in 1 BOTTLE (50228-344-30)
50228-344-905022803449090 TABLET, FILM COATED in 1 BOTTLE (50228-344-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/52332190-2a12-d205-e063-6394a90ab7c5

Use it

Look up 50228-344 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-344 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-344. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.